Logo image of BLLN

BILLIONTOONE INC CL A (BLLN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BLLN - US0901681058 - Common Stock

93.29 USD
-3.56 (-3.68%)
Last: 1/14/2026, 3:00:24 PM
Fundamental Rating

3

Overall BLLN gets a fundamental rating of 3 out of 10. We evaluated BLLN against 100 industry peers in the Health Care Providers & Services industry. BLLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLLN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • BLLN had negative earnings in the past year.
BLLN Yearly Net Income VS EBIT VS OCF VS FCFBLLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -12.69%, BLLN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • BLLN has a worse Return On Equity (-23.11%) than 67.00% of its industry peers.
Industry RankSector Rank
ROA -12.69%
ROE -23.11%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLLN Yearly ROA, ROE, ROICBLLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

  • The Gross Margin of BLLN (53.03%) is better than 76.00% of its industry peers.
  • The Profit Margin and Operating Margin are not available for BLLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLLN Yearly Profit, Operating, Gross MarginsBLLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

  • BLLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BLLN has about the same amout of shares outstanding than it did 1 year ago.
  • BLLN has a better debt/assets ratio than last year.
BLLN Yearly Shares OutstandingBLLN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M
BLLN Yearly Total Debt VS Total AssetsBLLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 17.43 indicates that BLLN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of BLLN (17.43) is better than 98.00% of its industry peers.
  • BLLN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.31, BLLN is doing good in the industry, outperforming 66.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 17.43
ROIC/WACCN/A
WACC8.95%
BLLN Yearly LT Debt VS Equity VS FCFBLLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 6.17 indicates that BLLN has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 6.17, BLLN belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
  • A Quick Ratio of 5.75 indicates that BLLN has no problem at all paying its short term obligations.
  • The Quick ratio of BLLN (5.75) is better than 94.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.17
Quick Ratio 5.75
BLLN Yearly Current Assets VS Current LiabilitesBLLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

  • BLLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.72%, which is quite impressive.
  • Looking at the last year, BLLN shows a very strong growth in Revenue. The Revenue has grown by 112.72%.
EPS 1Y (TTM)49.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)112.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • BLLN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.31% yearly.
  • The Revenue is expected to grow by 53.33% on average over the next years. This is a very strong growth
EPS Next Y118.01%
EPS Next 2Y51.34%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue Next Year97.8%
Revenue Next 2Y63.94%
Revenue Next 3Y53.33%
Revenue Next 5YN/A

3.3 Evolution

BLLN Yearly Revenue VS EstimatesBLLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
BLLN Yearly EPS VS EstimatesBLLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BLLN. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 345.51, which means the current valuation is very expensive for BLLN.
  • Based on the Price/Forward Earnings ratio, BLLN is valued a bit more expensive than 62.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLLN to the average of the S&P500 Index (24.04), we can say BLLN is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 345.51
BLLN Price Earnings VS Forward Price EarningsBLLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLLN Per share dataBLLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLLN does not grow enough to justify the current Price/Earnings ratio.
  • BLLN's earnings are expected to grow with 43.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y43.31%

More info and screens

0

5. Dividend

5.1 Amount

  • BLLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BILLIONTOONE INC CL A

NASDAQ:BLLN (1/14/2026, 3:00:24 PM)

93.29

-3.56 (-3.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-09
Earnings (Next)N/A
Inst Owners1.33%
Inst Owner Change26.65%
Ins Owners0.88%
Ins Owner Change-43.63%
Market Cap4.24B
Revenue(TTM)152.58M
Net Income(TTM)-41.57M
Analysts83.08
Price Target140.59 (50.7%)
Short Float %0.78%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 345.51
P/S 27.76
P/FCF N/A
P/OCF N/A
P/B 23.54
P/tB 23.54
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)0.27
Fwd EY0.29%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.36
BVpS3.96
TBVpS3.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.69%
ROE -23.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.17
Quick Ratio 5.75
Altman-Z 17.43
F-ScoreN/A
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y118.01%
EPS Next 2Y51.34%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue 1Y (TTM)112.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year97.8%
Revenue Next 2Y63.94%
Revenue Next 3Y53.33%
Revenue Next 5YN/A
EBIT growth 1Y32.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.91%
EBIT Next 3Y54.23%
EBIT Next 5YN/A
FCF growth 1Y21.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.91%
OCF growth 3YN/A
OCF growth 5YN/A

BILLIONTOONE INC CL A / BLLN FAQ

What is the ChartMill fundamental rating of BILLIONTOONE INC CL A (BLLN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLLN.


What is the valuation status for BLLN stock?

ChartMill assigns a valuation rating of 1 / 10 to BILLIONTOONE INC CL A (BLLN). This can be considered as Overvalued.


How profitable is BILLIONTOONE INC CL A (BLLN) stock?

BILLIONTOONE INC CL A (BLLN) has a profitability rating of 1 / 10.